Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) and U.S. Physical Therapy (NYSE:USPH – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability.
Earnings & Valuation
This table compares Fresenius SE & Co. and U.S. Physical Therapy”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Fresenius SE & Co. | $23.63 billion | N/A | $509.67 million | $0.55 | 25.42 |
| U.S. Physical Therapy | $758.71 million | 1.69 | $31.42 million | $2.38 | 35.47 |
Dividends
Fresenius SE & Co. pays an annual dividend of $0.19 per share and has a dividend yield of 1.4%. U.S. Physical Therapy pays an annual dividend of $1.80 per share and has a dividend yield of 2.1%. Fresenius SE & Co. pays out 34.5% of its earnings in the form of a dividend. U.S. Physical Therapy pays out 75.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. U.S. Physical Therapy has raised its dividend for 6 consecutive years. U.S. Physical Therapy is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Analyst Ratings
This is a summary of recent ratings for Fresenius SE & Co. and U.S. Physical Therapy, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Fresenius SE & Co. | 0 | 0 | 2 | 0 | 3.00 |
| U.S. Physical Therapy | 0 | 3 | 4 | 0 | 2.57 |
U.S. Physical Therapy has a consensus target price of $105.33, indicating a potential upside of 24.79%. Given U.S. Physical Therapy’s higher probable upside, analysts clearly believe U.S. Physical Therapy is more favorable than Fresenius SE & Co..
Profitability
This table compares Fresenius SE & Co. and U.S. Physical Therapy’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Fresenius SE & Co. | 5.26% | 9.72% | 4.48% |
| U.S. Physical Therapy | 5.71% | 8.62% | 3.64% |
Risk & Volatility
Fresenius SE & Co. has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, U.S. Physical Therapy has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500.
Summary
U.S. Physical Therapy beats Fresenius SE & Co. on 8 of the 14 factors compared between the two stocks.
About Fresenius SE & Co.
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Receive News & Ratings for Fresenius SE & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
